Iliuta Ioan-Andrei, Kalatharan Vinusha, Wang Kairong, Cornec-Le Gall Emilie, Conklin John, Pourafkari Marina, Ting Ryan, Chen Chen, Borgo Alessia C, He Ning, Song Xuewen, Heyer Christina M, Senum Sarah R, Hwang Young-Hwan, Paterson Andrew D, Harris Peter C, Khalili Korosh, Pei York
Division of Nephrology and.
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
J Am Soc Nephrol. 2017 Sep;28(9):2768-2776. doi: 10.1681/ASN.2016090938. Epub 2017 May 18.
The absence of a positive family history (PFH) in 10%-25% of patients poses a diagnostic challenge for autosomal dominant polycystic kidney disease (ADPKD). In the Toronto Genetic Epidemiology Study of Polycystic Kidney Disease, 210 affected probands underwent renal function testing, abdominal imaging, and comprehensive and mutation screening. From this cohort, we reviewed all patients with and without an apparent family history, examined their parental medical records, and performed renal imaging in all available parents of unknown disease status. Subsequent reclassification of 209 analyzed patients revealed 72.2% (151 of 209) with a PFH, 15.3% (32 of 209) with disease, 10.5% (22 of 209) with an indeterminate family history, and 1.9% (four of 209) with PFH in retrospect. Among the patients with cases, we found two families with germline mosaicism and one family with somatic mosaicism. Additionally, analysis of renal imaging revealed that 16.3% (34 of 209) of patients displayed atypical PKD, most of which followed one of three patterns: asymmetric or focal PKD with PFH and an identified or mutation (15 of 34), asymmetric and PKD with proven or suspected somatic mosaicism (seven of 34), or focal PKD without any identifiable or mutation (eight of 34). In conclusion, PKD without an apparent family history may be due to disease, missing parental medical records, germline or somatic mosaicism, or mild disease from hypomorphic and mutations. Furthermore, mutations of a newly identified gene for ADPKD, , and somatic mosaicism need to be considered in the mutation-negative patients with focal disease.
10% - 25%的常染色体显性多囊肾病(ADPKD)患者缺乏阳性家族史(PFH),这给该病的诊断带来了挑战。在多伦多多囊肾病基因流行病学研究中,210名受影响的先证者接受了肾功能测试、腹部成像以及全面的突变筛查。在这个队列中,我们审查了所有有或无明显家族史的患者,检查了他们父母的病历,并对所有疾病状态不明的在世父母进行了肾脏成像检查。随后对209名分析对象的重新分类显示,72.2%(209名中的151名)有PFH,15.3%(209名中的32名)患有该病,10.5%(209名中的22名)家族史不确定,1.9%(209名中的4名)回顾性分析有PFH。在患病患者中,我们发现了两个存在生殖系嵌合体的家族和一个存在体细胞嵌合体的家族。此外,肾脏成像分析显示,16.3%(209名中的34名)的患者表现为非典型多囊肾病,其中大多数遵循三种模式之一:有PFH且有已识别的或突变的不对称或局灶性多囊肾病(34名中的15名)、有已证实或疑似体细胞嵌合体的不对称和多囊肾病(34名中的7名)、或无任何可识别的或突变的局灶性多囊肾病(34名中的8名)。总之,无明显家族史的多囊肾病可能归因于疾病、父母病历缺失、生殖系或体细胞嵌合体,或因低表达和突变导致的轻症疾病。此外,对于局灶性疾病且突变阴性的患者,需要考虑新发现的ADPKD基因的突变以及体细胞嵌合体。